You are here: Industry Insights > IFPMA

News List

100 Days Mission: “landmark collaboration” to protect people against future pandemics europeanpharmaceuticalreview
June 04, 2021
Governments and life science leaders agree to work towards slashing the time to develop and deploy interventions and diagnostics for future pandemic threats to 100 days.
Biopharma industry commits to working with regulatory agencies on COVID-19 vaccines europeanpharmaceuticalreview
January 15, 2021
A statement from biopharmaceutical industry groups has said they plan to work with regulatory agencies to gather data on COVID-19 vaccines.
Drugmakers partner to launch $1bn fund for antibiotics development pharmaceutical-technology
July 13, 2020
More than 20 major biopharmaceutical companies, including Pfizer, GlaxoSmithKline and Johnson & Johnson, have partnered to launch the AMR Action Fund with an aim to provide two to four new antibiotics to patients by 2030.
Global Biopharmaceutical Industry pulling out all the stops to address Coronavirus public health crisis expresspharma
March 25, 2020
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the world’s leading biopharmaceutical companies ...
IFPMA’s new code bans all gifts – no exceptions! pharmaphorum
January 15, 2019
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has published its new code of practice, introducing a total ban on gifts and promotional items for prescription drugs for the first time.